5HT1A-mediated stimulation of cortisol release in major depression: Use of non-invasive cortisol measurements to predict clinical response

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue 2, 2010, Pages 175-180

  Papakostas, George I ^a   Chuzi, Sarah E ^a   Sousa, Jessica L ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

5 HT1A; Buspirone; Cortisol; Escitalopram; Major depressive disorder

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; DESVENLAFAXINE; ESCITALOPRAM; FLUOXETINE; HYDROCORTISONE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PHENELZINE; TRAZODONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; MAJOR DEPRESSION; MALE; PREDICTION; PRIORITY JOURNAL; REMISSION; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGED; BUSPIRONE; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; SALIVA; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 77950862842     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-009-0035-z     Document Type: Article

References (39)

1. JD Amsterdam A Winokur S Bryant J Larkin K Rickels 1983 The dexamethasone suppression test as a predictor of treatment response Psychopharmacology (Berl) 80 43 45 10.1007/BF00427493 1:STN:280:DyaL3s3ksl2itg%3D%3D (Pubitemid 13123883)
2. JH Atkinson Jr EF Kremer SC Risch R Dana DS Janowsky 1986 Neuroendocrine responses in psychiatric and pain patients with major depression Biol Psychiatry 21 7 612 620 10.1016/0006-3223(86)90122-8 3708035 (Pubitemid 16042940)
3. TC Baghai C Schüle P Zwanzger C Minov C Holme F Padberg M Bidlingmaier CJ Strasburger R Rupprecht 2002 Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression Psychoneuroendocrinology 27 3 385 399 10.1016/S0306-4530(01)00060-9 1:CAS:528:DC%2BD38XovFWmsg%3D%3D 11818173 (Pubitemid 34121980)
4. CM Banki G Bissette M Arato L O'Connor CB Nemeroff 1987 CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia Am J Psychiatry 144 873 877 1:STN:280:DyaL2s3mvVWntA%3D%3D 3496802 (Pubitemid 17095723)
5. A Baumgartner KJ Graf I Kurten 1986 Serial dexamethasone suppression tests in psychiatric illness: PartII. A study in major depressive disorder Psychiatry Res 18 1 25 43 10.1016/0165-1781(86)90058-2 1:STN:280: DyaL283oslOltQ%3D%3D 3737786 (Pubitemid 16085765)
6. I Berlin D Warot V Legout S Guillemant G Schollnhammer A Puech 1998 Blunted 5-HT-1A receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects Clin Pharmacol Ther 63 4 428 436 10.1016/S0009-9236(98)90038-8 1:CAS:528:DyaK1cXjt1Sgtrg%3D 9585797 (Pubitemid 28214966)
7. P Blier 2001 Pharmacology of rapid-onset antidepressant treatment strategies J Clin Psychiatry 62 12 17 1:CAS:528:DC%2BD3MXltlKjt7w%3D 11444761 (Pubitemid 32601343)
8. R Catalan JM Gallard JM Castellanos R Galard 1998 Plasma corticotropin-releasing factor in depressive disorders Biol Psychiatry 44 15 20 10.1016/S0006-3223(97)00539-8 1:CAS:528:DyaK1cXkt1Kjurk%3D 9646879 (Pubitemid 28305537)
9. PJ Cowen 2000 Psychopharmacology of 5-HT(1A) receptors Nucl Med Biol 27 5 437 439 10.1016/S0969-8051(00)00108-6 1:CAS:528:DC%2BD3cXmtVGjt7g%3D 10962247 (Pubitemid 30658143)
10. JF Cryan BE Leonard 2000 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response Hum Psychopharmacol 15 2 113 135 10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W 1:CAS:528:DC%2BD3cXjt1CktLc%3D 12404340 (Pubitemid 30199285)
11. RE Dahl ND Ryan J Puig-Antich NA Nguyen M al-Shabbout VA Meyer J Perel 1991 24-hour cortisol measures in adolescents with major depression: a controlled study Biol Psychiatry 30 1 25 36 10.1016/0006-3223(91)90067-V 1:STN:280:DyaK3MzntVWmtw%3D%3D 1892959
12. TG Dinan 1996 Serotonin and the regulation of hypothalamic-pituitary- adrenal axis function Life Sci 58 20 1683 1694 10.1016/0024-3205(96)00066-5 1:CAS:528:DyaK28XisFSktbk%3D 8637392 (Pubitemid 26147104)
13. WC Drevets ME Thase EL Moses-Kolko J Price E Frank DJ Kupfer C Mathis 2007 Serotonin-1A receptor imaging in recurrent depression: replication and literature review Nucl Med Biol 34 7 865 877 10.1016/j.nucmedbio.2007.06.008 1:CAS:528:DC%2BD2sXhtFeiu7%2FJ 17921037 (Pubitemid 47505401)
14. DL Evans CB Nemeroff JJ Haggerty Jr CA Pedersen 1987 Use of the dexamethazone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents Psychoneuroendocrinology 12 3 203 209 10.1016/0306-4530(87)90005-9 1:STN:280:DyaL2s3ptVelsg%3D%3D 3615749 (Pubitemid 17095624)
15. First BM, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders-patient edition (SCID I/P). Biometrics Research Department, State Psychiatric Institute, New York
16. R Galard JM Gallart R Catalan S Schwartz JM Arguello JM Castellanos 1991 Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST Am J Psychiatry 148 4 505 508 1:STN:280:DyaK3M7nsVSrug%3D%3D 1848739
17. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 10.1136/jnnp.23.1.56 1:STN:280:DyaF3c7ltFyksw%3D%3D 14399272
18. M Ising S Horstmann S Kloiber S Lucae EB Binder N Kern HE Künzel A Pfennig M Uhr F Holsboer 2007 Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker? Biol Psychiatry 62 1 47 54 10.1016/j.biopsych.2006.07.039 1:CAS:528:DC%2BD2sXmsFKrurw%3D 17123470 (Pubitemid 46898222)
19. M Ising HE Künzel EB Binder T Nickel S Modell F Holsboer 2005 The combined dexamethasone/CRH test as a potential surrogate marker in depression Prog Neuropsychopharmacol Biol Psychiatry 29 6 1085 1093 10.1016/j.pnpbp.2005. 03.014 1:CAS:528:DC%2BD2MXntVGntrk%3D 15950349 (Pubitemid 41080135)
20. PG Janicak GN Pandey R Sharma R Boshes D Bresnahan JM Davis 1987 Pretreatment dexamethasone suppression test as a predictor of response to phenelzine J Clin Psychiatry 48 12 480 482 1:STN:280:DyaL1c%2Fos12gtw%3D%3D 3693333 (Pubitemid 18023390)
21. NM Kin NP Nair G Schwartz SK Ahmed P Holm C Katona P Kragh-Sorensen N Klitgaard WY Song TE West K Stage 1997 The dexamethazone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline Biol Psychiatry 42 10 925 931 10.1016/S0006-3223(97)00158-3 1:CAS:528: DyaK2sXnsVenurk%3D 9359979 (Pubitemid 27486447)
22. BE Leonard 2005 The HPA and immune axes in stress: the involvement of the serotonergic system Eur Psychiatry 20 3 S302 S306 10.1016/S0924-9338(05)80180-4 16459240 (Pubitemid 43184092)
23. B Lerer Y Gelfin M Gorfine B Allolio KP Lesch ME Newman 1999 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge Neuropsychopharmacology 20 6 628 639 10.1016/S0893-133X(98)00106-7 1:CAS:528:DyaK1MXjsValsr4%3D 10327431 (Pubitemid 29189266)
24. P Linkowski J Mandlewicz M Kerkhofs R Leclercq J Goldstein M Brasseur G Copinschi E Van Cauter 1987 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment J Clin Endocrinol Metab 65 1 141 152 10.1210/jcem-65-1-141 1:STN:280:DyaL2s3it12hsw%3D%3D 3034952 (Pubitemid 17092102)
25. A Michael A Jenaway ES Paykel J Herbert 2000 Altered salivary dehydroepiandrosterone levels in major depression Biol Psychiatry 48 10 989 995 10.1016/S0006-3223(00)00955-0 1:CAS:528:DC%2BD3cXotVOjurs%3D 11082473
26. AP Moffoot RE O'Carroll J Bennie S Carroll H Dick KP Ebmeier GM Goodwin 1994 Diurnal variation of mood and neuropsychological function in major depression with melancholia J Affect Disord 32 4 257 269 10.1016/0165-0327(94) 90090-6 1:STN:280:DyaK2M3gsVOrsw%3D%3D 7897090
27. R Navinés R Martín-Santos E Gómez-Gil MJ Martínez de Osaba ML Imaz C Gastó 2007 Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response Psychoneuroendocrinology 32 4 411 416 10.1016/j.psyneuen.2007.01.006 17337123 (Pubitemid 46617778)
28. SM O'Toole LK Sekula RT Rubin 1997 Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression Biol Psychiatry 42 2 85 89 10.1016/S0006-3223(96)00293-4 9209724 (Pubitemid 27276070)
29. PM Plotsky MH Owens CB Nemeroff 1998 Psychoneuroendocrinology of depression Hypothalamic-pituitary-adrenal axis Psychiatr Clin North Am 21 2 293 307 10.1016/S0193-953X(05)70006-X 1:STN:280:DyaK1czjsVyrsQ%3D%3D 9670227 (Pubitemid 28311852)
30. JA Posener C deBattista GH Williams H Chmura Kraemer BM Kalezhan AF Schatzberg 2000 24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression Arch Gen Psychiatry 57 8 755 760 10.1001/archpsyc.57.8.755 1:CAS:528:DC%2BD3cXlvFKgt74%3D 10920463
31. FC Raadscheer WJG Hoogendijk FC Stam FJH Tilders DF Swaab 1994 Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients Neuroendocrinology 60 436 443 10.1159/000126778
32. JL Rausch SM Stahl RL Hauger 1990 Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients Biol Psychiatry 28 1 73 78 10.1016/0006-3223(90)90434-4 1:CAS:528:DyaK3cXkvFWku7g%3D 1973905 (Pubitemid 20210886)
33. C Schüle TC Baghai D Eser S Häfner C Born S Herrmann R Rupprecht 2009 The combined dexamethasone/CRH test (DEX/CRH test) and prediction of acute treatment response in major depression PLoS ONE 4 1 e4324 10.1371/journal.pone.0004324 19177168
34. SM Stahl 1992 Neuroendocrine markers of serotonin responsivity in depression Prog Neuropsychopharmacol Biol Psychiatry 16 5 655 659 10.1016/0278-5846(92)90022-7 1:CAS:528:DyaK3sXlslWmsw%3D%3D 1496123
35. S Stahl 1994 5HT1A receptors and pharmacotherapy: Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 30 1 39 43 1:CAS:528:DyaK2cXmsVCku7w%3D 7972628
36. SM Stahl 1998 Mechanism of action of selective serotonin reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects J Affect Disord 51 3 215 235 10.1016/S0165-0327(98)00221-3 1:STN:280:DyaK1M3ms1Ghsw%3D%3D 10333979 (Pubitemid 29202172)
37. ME Thase S Dube K Bowler RH Howland JE Myers 1996 Hypothalamic-pituitary- adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients Am J Psychiatry 153 7 886 891 1:STN:280:DyaK283lvFCktw%3D%3D 8659610 (Pubitemid 26225462)
38. B Weber S Lewicka M Deuschle M Colla P Vecsei I Heuser 2000 Increased diurnal plasma concentrations of cortisone in depressed patients J Clin Endocrinol Metab 85 3 1133 1136 10.1210/jc.85.3.1133 1:CAS:528: DC%2BD3cXisFOqsrw%3D 10720051 (Pubitemid 32269361)
39. ML Wong MA Kling PJ Munson S Listwak J Licino P Prolo B Karp IE McCutcheon TJ Geracioti Jr MD DeBellis KC Rice DS Goldstein JD Veldhuis GP Chrousos EH Oldfield SM McCann PW Gold 2000 Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone Proc Natl Acad Sci USA 97 1 325 330 10.1073/pnas.97.1.325 1:CAS:528:DC%2BD3cXjvVGitA%3D%3D 10618417 (Pubitemid 30055830)